CARSON CITY, NV, May 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - Pharmagreen Biotech, Inc., (OTCQB: PHBI), (“Pharmagreen” or the “Company”), which provides the highest quality starter plantlets utilizing a proprietary tissue culture process, "Chibafreen," to licensed cannabis cultivators and CBD / CBG hemp farmers, announces that it has completed another significant milestone in the business development with Long Valley Farms. Pharmagreen has advanced the next tranche of funds, whereby the use of proceeds is for the continuous application process for the LVF micro-business license and its nursery licenses in addition to the current cultivation license. PHBI anticipates having the permits in place within the following few months, depending on the regulator’s schedule.

The significance of completing and receiving the licenses will allow for immediate revenues, primarily generated from the sales of live rosin and biomass to other cannabis manufacturers, distributors, and retailers. The micro-business permissions allow for vertical sales channels up to and including retail direct from the farm, thereby capturing 100% of the revenue minus the taxes owed.

The live rosin production and sales are estimated to bring in up to $18K per day in gross revenues alongside minimal capital expenditures. Existing infrastructure and equipment are in place. With Long Valley Farms’ (LVF) non-spray and vegan certifications, proprietary proven process for live rosin production, and biomass in stock, the Company has the technology, know-how, and supply to manufacture a highly desirable organic live rosin product.

Pharmagreen has advanced the third tranche of funds to LVF to ensure that vertical business growth is successfully implemented, since being a cultivator alone in the Cannabis industry is no longer a viable enterprise. Cultivators in California are getting about 10% of the industry dollar. Having the ability to sell as a distributor to manufacturers and retailers, including direct to retail products beyond just flower tops, is much more profitable. The retail price per gram has remained relatively stable; what has shifted is how that revenue is distrusted among licensed industry players.

“Being vertically integrated is the answer to being a successful and profitable company in the cannabis space. Pharmagreen teams are highly experienced in the Cannabis and agro-technology industries, capable of producing pharmaceutical-grade raw materials for whole plant therapeutics and beyond. We want to make sure our efforts increase the bottom line as much as possible and making these moves toward vertical integration is the key to that plan,” stated Peter Wojcik, CEO of Pharmagreen.

Visit update.pharmagren.ca for additional information on PHBI's current business development.

To watch the video on our recent business developments, please click here.

About Long Valley Farms LLC.

Long Valley Farms is a vegan cannabis farm located in the heart of the emerald triangle. The company was started to further the quality of California sun-grown cannabis and is currently being operated with the latest technologies as a Vegan, non-spray, no-till Cannabis farm. It cultivates legacy and heritage strains for organically produced highest-quality flower tops.

Pharmagreen Biotech, Inc. (OTCQB: PHBI) is in the business of providing the highest quality starter plantlets utilizing a proprietary tissue culture process, "Chibafreen," to licensed cannabis cultivators and CBD / CBG hemp farmers. It also provides other value-added services, including plant species identification through DNA testing and certification, live storage of all plant strains using tissue culture, and proprietary low-temperature storage technology. The company utilizes the best tissue cultured plantlets in its state-of-the-art greenhouse(s) for the highest quality flower tops production. For further information on the company, please visit www.pharmagreen.ca

This press release contains forward-looking statements. Such forward-looking statements are subject to several risks, assumptions and uncertainties that could cause the company's actual results to differ materially from those projected in such forward-looking statements. In particular, factors that could cause actual results to differ materially from those in forward-looking statements include our inability to obtain additional financing on acceptable terms; risk that our products and services will not gain widespread market acceptance; failure to compete with others who provide comparable products; the loss of our technology; the infringement of our technology with proprietary rights of third parties; inability to respond to consumer demands; failure to replace significant customers; seasonal nature of our business. Forward-looking statements speak only as of the date made and are not guaranteed future performance. We undertake no obligation to update or revise any forward-looking statements publicly. When used in this document, the words "believe," "expect," "anticipate," "estimate," "project," "plan," "should," "intend," "may," "will," and "would," "potential," and similar expressions may be used to identify forward-looking statements.

The OTC Markets or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release that has been prepared by management.

Contact Information: Current business development: Update.pharmagreen.ca Website: www.pharmagreen.ca Tel: (702) 803 9404 Email: info@pharmagreen.ca

Bridgewater’s co–chief investment officer said the U.S. economy could slow down further.

The rate of U.S. inflation reached a 40-year high of 8.6% in May as overall prices for things including rent, gas and food all remain on the rise. “I personally believe that this inflation is here to stay for quite some time,” Orman recently told CNBC, prior to the release of May’s CPI data from the U.S. Bureau of Labor Statistics. The first is a fixed rate when the purchaser buys the bond, and the second is the inflation adjustment rate, which is reset every six months based on inflation.

Yahoo Finance Live’s Brian Sozzi, Brad Smith, and Julie Hyman discuss quarterly earnings for DocuSign.

The U.S. hasn't yet entered a recession -- which is officially defined as two consecutive quarters of negative GDP growth -- but runaway inflation, stagnant wages, food shortages, rising interest rates, and geopolitical turmoil could all break this fragile economy's back in the near future. If that happens, growth stocks will fall further as value stocks become even more attractive. Altria is the top tobacco company in America.

Amazon's (NASDAQ: AMZN) stock split has taken effect, and it is now trading on an adjusted basis. Let's take a closer look at why Amazon's more profitable segments and a relatively inexpensive valuation should be the basis for your investment decisions on this stock. Amazon's 20-for-1 stock split does not change your share of the ownership pie.

Since taking the reins as CEO of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) in 1965, Warren Buffett has put on a moneymaking clinic for Wall Street. While there are no shortage of reasons for the Oracle of Omaha's sustained success, his love of dividend stocks could be the most important component. Dividend stocks are almost always profitable and time-tested.

ChargePoint, Autoliv, and QuantumScape look like excellent long-term bets, despite the near-term headwinds they face.

Be greedy (but selective) when others are fearful.

Friday’s consumer-price index report for May — which showed the annual headline U.S. inflation rate climbing to 8.6% in May, with few signs of having peaked — is boosting the chances of a jumbo-sized rate increase by monetary-policy makers as soon as next week, and eliciting dire warnings that central bankers have completely lost control of prices. Fed funds futures traders now see a 21% chance of a 75-basis-point hike in June, up from just 3.6% on Thursday, according to the CME FedWatch Tool. Beneath the issue of where the Fed goes from here is a much more fundamental and serious problem: Some observers fear the U.S. central bank has already effectively lost control of inflation.

Inflation has yet to peak and has only gotten worse since 2021, Tim Magnusson, chief investment officer of Garda Capital Partners, tells MarketWatch.

Inflation remains white-hot. These stocks can help stop the pain.

Markets are volatile. Use these dividend stocks for peace of mind.

Investors have some big questions ahead of the upcoming earnings update from Adobe (NASDAQ: ADBE). The cloud services specialist announces its operating results on Thursday, June 16, after the market closes. Shareholders will also learn whether challenges like inflation and slowing economic growth threaten management's bullish outlook for 2022.

Want to bet on a bounce? Consider these three stocks first.

A top executive at Walt Disney is leaving nearly a year after renewing his contract in what might be just the latest headache for the entertainment giant and its stock. The media giant said Thursday that Dana Walden would succeed Peter Rice as chairman of general entertainment content, effective immediately. Rice joined Disney (ticker: DIS) in 2019 as part of the 21st Century Fox acquisition.

(Bloomberg) -- Traders are now fully pricing three half-point Federal Reserve rate hikes in coming months, while the 30-year Treasury yield fell below its five-year counterpart for the first time in a month. Most Read from BloombergUS Lifts Covid-19 Test Requirement for International TravelUS Inflation Quickens to 40-Year High, Pressuring Fed and BidenEating Two Portions of Fish Per Week Linked to Deadly Skin CancerFive Key Moments From the Jan. 6 Capitol Riot HearingStocks Reel, Bond Yields Sur

AMD painted a bright picture of its growing market opportunity, especially in data centers, at an analyst day presentation.

Low rates and high inflation make cash tough to hold. Look here instead.

In this article, we discuss the 10 safe blue chip stocks to buy in June. If you want to skip our detailed analysis of the current market situation and blue chip stocks, go directly to 5 Safe Blue Chip Stocks to Buy in June. Inflation is eating away at the purchasing power of consumers across the […]

Inflation and rising mortgage costs are putting a dent in housing prices, which in turn is reducing lumber demand.